Healthcare provider profile · identity verified

Julia T Hemphill, MD

Family Practice · SHAWSVILLE, VA · NPI 1669452066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	428	119
Levothyroxine Sodium	Levothyroxine Sodium	343	78
Losartan Potassium	Losartan Potassium	342	93
Gabapentin	Gabapentin	317	66
Atorvastatin Calcium	Atorvastatin Calcium	305	84
Lisinopril	Lisinopril	272	73
Simvastatin	Simvastatin	232	59
Pantoprazole Sodium	Pantoprazole Sodium	203	60
Rosuvastatin Calcium	Rosuvastatin Calcium	201	58
Hydrochlorothiazide	Hydrochlorothiazide	199	59
Escitalopram Oxalate	Escitalopram Oxalate	183	46
Metformin Hcl Er	Metformin Hcl	181	54
Sertraline Hcl	Sertraline Hcl	178	47
Trazodone Hcl	Trazodone Hcl	173	53
Duloxetine Hcl	Duloxetine Hcl	169	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	167	45
Omeprazole	Omeprazole	161	48
Metoprolol Succinate	Metoprolol Succinate	159	40
Famotidine	Famotidine	145	44
Tamsulosin Hcl	Tamsulosin Hcl	140	44
Jardiance	Empagliflozin	133	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	128	39
Buspirone Hcl	Buspirone Hcl	114	28
Pravastatin Sodium	Pravastatin Sodium	111	29
Potassium Chloride	Potassium Chloride	110	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	102	25
Bupropion Xl	Bupropion Hcl	99	24
Metoprolol Tartrate	Metoprolol Tartrate	98	24
Eliquis	Apixaban	97	23
Albuterol Sulfate Hfa	Albuterol Sulfate	93	42
Alendronate Sodium	Alendronate Sodium	91	27
Metformin Hcl	Metformin Hcl	88	24
Glimepiride	Glimepiride	84	27
Mirtazapine	Mirtazapine	84	23
Meloxicam	Meloxicam	78	27
Triamcinolone Acetonide	Triamcinolone Acetonide	78	32
Fluticasone Propionate	Fluticasone Propionate	72	24
Furosemide	Furosemide	72	35
Ozempic	Semaglutide	72	11
Pregabalin	Pregabalin	69	12
Carvedilol	Carvedilol	67	21
Warfarin Sodium	Warfarin Sodium	67	15
Tramadol Hcl	Tramadol Hcl	65	15
Donepezil Hcl	Donepezil Hcl	64	16
Fluoxetine Hcl	Fluoxetine Hcl	62	16
Clopidogrel	Clopidogrel Bisulfate	59	15
Clonazepam	Clonazepam	56	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	54	46
Trulicity	Dulaglutide	54	suppressed
Spironolactone	Spironolactone	53	15
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	11
Meclizine Hcl	Meclizine Hcl	49	13
Allopurinol	Allopurinol	47	16
Topiramate	Topiramate	47	suppressed
Hydralazine Hcl	Hydralazine Hcl	46	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	44	11
Alprazolam	Alprazolam	43	13
Prednisone	Prednisone	43	36
Ropinirole Hcl	Ropinirole Hcl	43	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	suppressed
Propranolol Hcl	Propranolol Hcl	36	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Cephalexin	Cephalexin	34	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	34	13
Ondansetron Hcl	Ondansetron Hcl	34	15
Lorazepam	Lorazepam	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	11
Mounjaro	Tirzepatide	32	suppressed
Nebivolol Hcl	Nebivolol Hcl	31	suppressed
Rybelsus	Semaglutide	31	11
Celecoxib	Celecoxib	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	16
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	12
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Estradiol	Estradiol	26	11
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Novolog Flexpen	Insulin Aspart	25	suppressed
Myrbetriq	Mirabegron	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	14
Hydroxyzine Pamoate	Hydroxyzine Pamoate	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Azelastine Hcl	Azelastine Hcl	18	suppressed
Finasteride	Finasteride	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	13
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Colchicine	Colchicine	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	suppressed
Nystatin	Nystatin	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Atenolol	Atenolol	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Colestipol Hcl	Colestipol Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ammonium Lactate	Ammonium Lactate	13	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Digoxin	Digoxin	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Naproxen	Naproxen	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Pen Needles	Pen Needle, Diabetic	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Alogliptin	Alogliptin Benzoate	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Isosorbide Mononitrate	Isosorbide Mononitrate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error